Drotrecogin Alfa
Products Drotrecogin alfa was commercially available as a lyophilizate (Xigris). It has been approved in many countries and in the EU since 2002 and was also available in the United States and Canada. In 2011, Eli Lilly announced it was withdrawing the drug from the market worldwide. The PROWESS-SHOCK study showed insufficient efficacy. Mortality was … Drotrecogin Alfa
